Suszko Agnieszka, Obmińska-Mrukowicz Bożena
Department of Biochemistry, Pharmacology & Toxicology, Faculty of Veterinary Medicine, Wrocław University of Environmental & Life Sciences, 50-375 Wrocław, Poland.
Indian J Med Res. 2017 Feb;145(2):229-236. doi: 10.4103/ijmr.IJMR_704_14.
BACKGROUND & OBJECTIVES: The extracts from Caltha palustris L. have been shown to be beneficial for treating arthritis and rheumatism. In this study, the immunomodulatory effects of polysaccharide fractions B and C of C. palustris extracts were studied, using the collagen-induced arthritis (CIA) mouse arthritis experimental model. The aim was to determine the activity of blood phagocytic cells and humoral immune response in CIA mice treated with polysaccharide fractions from C. palustris.
The effects of fractions B and C of C. palustris were explored by evaluating phagocytic activity of peripheral blood granulocytes and monocytes and humoral immune response in sheep red blood cell (SRBC)-immunized mice. The results were compared with methotrexate (MTX) treatment. Following the onset of CIA, DBA/1J mice were treated for 21 days with B or C fractions (10 mg/kg; i.p.) or MTX (every 48 h, 6.6 mg/kg; i.p.).
The results showed that fraction B reduced the level of interleukin (IL)-1β, boosted nitric oxide synthesis in murine peritoneal macrophages stimulated in vitro with lipopolysaccharide and enhanced the monocyte phagocytic activity. Exposure of SRBC-immunized mice to fraction B and MTX during the course of CIA resulted in decreased total anti-SRBC haemagglutinin titres.
INTERPRETATION & CONCLUSIONS: Fraction B of C. palustris polysaccharides modulated macrophage function and exerted beneficial effects on the clinical course of CIA in mice. The results also suggested efficacy of fraction B was comparable to that of MTX treatment for certain parameters.
已证明沼生马先蒿提取物对治疗关节炎和风湿病有益。在本研究中,利用胶原诱导的关节炎(CIA)小鼠关节炎实验模型,研究了沼生马先蒿提取物多糖组分B和C的免疫调节作用。目的是确定用沼生马先蒿多糖组分处理的CIA小鼠血液吞噬细胞活性和体液免疫反应。
通过评估外周血粒细胞和单核细胞的吞噬活性以及绵羊红细胞(SRBC)免疫小鼠的体液免疫反应,探讨沼生马先蒿组分B和C的作用。将结果与甲氨蝶呤(MTX)治疗进行比较。CIA发病后,DBA/1J小鼠用组分B或C(10mg/kg;腹腔注射)或MTX(每48小时,6.6mg/kg;腹腔注射)治疗21天。
结果表明,组分B降低了白细胞介素(IL)-1β水平,增强了脂多糖体外刺激的小鼠腹腔巨噬细胞中一氧化氮的合成,并增强了单核细胞吞噬活性。在CIA病程中,将SRBC免疫小鼠暴露于组分B和MTX导致总抗SRBC血凝素滴度降低。
沼生马先蒿多糖组分B调节巨噬细胞功能,并对小鼠CIA的临床病程产生有益影响。结果还表明,在某些参数上,组分B的疗效与MTX治疗相当。